2015
DOI: 10.1016/j.jmgm.2015.06.006
|View full text |Cite
|
Sign up to set email alerts
|

The study of dual COX-2/5-LOX inhibitors by using electronic-topological approach based on data on the ligand–receptor interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…This study has indicated that thiazole-possessing compound 14 remarkably decreased the neurotoxicity induced by ROS at 10 µM concentrations. In addition, the mentioned compound showed the best lipid peroxidation (LPO) inhibition and in vivo neuroprotective activities using gerbils as animal models [117,118]: (13), (14). Thiazole derivatives and related compounds reported as antioxidant agents.…”
Section: Antioxidant Agentsmentioning
confidence: 99%
“…This study has indicated that thiazole-possessing compound 14 remarkably decreased the neurotoxicity induced by ROS at 10 µM concentrations. In addition, the mentioned compound showed the best lipid peroxidation (LPO) inhibition and in vivo neuroprotective activities using gerbils as animal models [117,118]: (13), (14). Thiazole derivatives and related compounds reported as antioxidant agents.…”
Section: Antioxidant Agentsmentioning
confidence: 99%
“…COX2 and LOX-5 mediated biosynthesis of AA-DLMs, plays an important role in the inflammation process, which occur in different conditions including rheumatoid arthritis, neuroinflammation and psoriasis [53e55]. Due to the contribution of COX-2 and LOX-5 in the inflammatory process, there is a large interest in the use of new drugs as inhibitors of these oxygenase enzymes [56,57]. Recently, the upregulation of COX-2 was reported in situations where antiangiogenic therapies were applied, specifically in treatment with anti-VEGFR-2 antibodies and sunitinib.…”
Section: Cyclooxygenase 2 (Cox-2) and 5-lipoxygenase (Lox-5)mentioning
confidence: 99%